5Y1.F IQ-AI LTD. LS -01

Healthcare Health Care Technology Frankfurt Exchange
0.0005 EUR
Close of Nov 11, 2026
0.0005 0.0170
Market cap
EUR 123K
P/E
-
P/B
0.21x
ROE
-98.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 5Y1.F undervalued?

Graham number

The Graham number of IQ-AI LTD. LS -01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

IQ-AI LTD. LS -01 fundamental analysis

No fundamental analysis for IQ-AI LTD. LS -01 yet.

IQ-AI LTD. LS -01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About IQ-AI LTD. LS -01

Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro, an MRI perfusion platform that generates quantitative relative cerebral blood v…

Full company profile